Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Neurology | Musculoskeletal | Family Medicine
Disease Category: Fibromyalgia
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Depression with Fibromyalgia

Purpose

A Phase 3B Multicenter, Double-Blind, Randomized, Placebo Controlled, 2 Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia with Concurrent Antidepressant Therapy For Comorbid Depression (Protocol A0081275)

Patient Inclusion Criteria:

  • Men or Women who are at least 18 years of age
  • Documented diagnosis of depression

Patient Exclusion Criteria:

  • Use of prohibited pain/sleep medications Washout required prior to study entry
  • Subjects with pain due to other conditions
  • Clinically unstable, cardiovascular, hematological, autoimmune, endocrine, renal, hepatic, retinal or gastrointestinal disease.

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Cher Struck, Director Marketing and Recruiting
Lifetree Clinical Research
3838 South 700 East Suite 202
Salt Lake CIty, UT 84106
Phone: 801-269-8200

View Map

Research Center Information: Lifetree Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180848

Date Last Changed: July 19, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.